Lv11
46 积分 2023-07-16 加入
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
3小时前
已完结
儿童青少年非霍奇金淋巴瘤诊治专家共识（2026版）
1个月前
已完结
Hematopoietic stem cell transplantation activity in China 2022–2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group
2个月前
已完结
[China lymphoma diagnosis and treatment guideline (2026 edition)]
4个月前
已完结
[Expert consensus on the management practice of CD19 CAR-T cell therapy for B-cell lymphoma in China (2025 edition)]
4个月前
已完结
The paradox of the spleen: is it a nodal or extranodal site of lymphoma?
5个月前
已完结
Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte
9个月前
已完结
Therapeutic targeting of CD19 in hematological malignancies: past, present, future and beyond
1年前
已完结
皖公网安备34019202002308
